Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous bone marrow-derived mesenchymal stem cell infusion for dementia (STR01-06)
jRCT1090220331Not yet recruiting
- Sponsor
- Chiaki Kawanishi, MD, PhD
- Start
- Feb 2018
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Randomised, open-label trial of autologous bone marrow derived mesenchymal stromal cells in Dementia (2 arms), sponsored by Chiaki Kawanishi, MD, PhD. Planned start Feb 2018; status: not yet recruiting.
02
Drugs
autologous bone marrow derived mesenchymal stromal cells
03
Conditions
Dementia
Beyond the preview
Go deeper on jRCT1090220331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1090220331.